Cargando…
Identification and Validation of Two Lung Adenocarcinoma-Development Characteristic Gene Sets for Diagnosing Lung Adenocarcinoma and Predicting Prognosis
Background: Lung adenocarcinoma (LUAD) is one of the main types of lung cancer. Because of its low early diagnosis rate, poor late prognosis, and high mortality, it is of great significance to find biomarkers for diagnosis and prognosis. Methods: Five hundred and twelve LUADs from The Cancer Genome...
Autores principales: | Liu, Cheng, Li, Xiang, Shao, Hua, Li, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779611/ https://www.ncbi.nlm.nih.gov/pubmed/33408736 http://dx.doi.org/10.3389/fgene.2020.565206 |
Ejemplares similares
-
Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
por: Lv, Yanju, et al.
Publicado: (2022) -
Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022) -
Analysis of the Clinicopathologic Characteristics of Lung Adenocarcinoma With CTNNB1 Mutation
por: Zhou, Chao, et al.
Publicado: (2020) -
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021) -
Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma
por: Li, Yong, et al.
Publicado: (2022)